Comparing ALGN and PAYC: A Deep Dive into Volatility, Price Growth, and Earnings Reports
Compare: Swing Trader for Beginners: Exits from Low Volatility to Explosive Movements (TA&FA) 6.32% for ALGN vs Swing Trader for Beginners: Trading in Markets Trending Up (TA&FA) 6.58% for PAYC
A Brief Overview of Swing Trading Strategies
To start, let's briefly touch on the Swing Trading strategies referenced for ALGN and PAYC. The Swing Trader for Beginners: Exits from Low Volatility to Explosive Movements (TA&FA) strategy delivered a return of 6.32% for ALGN, while the Swing Trader for Beginners: Trading in Markets Trending Up (TA&FA) approach gave a return of 6.58% for PAYC. Though these strategies have unique characteristics, both apply technical and fundamental analysis (TA&FA) to navigate market volatility and trends.
The Exits from Low Volatility to Explosive Movements strategy typically involves trading stocks that exhibit periods of low volatility followed by large price movements, whereas Trading in Markets Trending Up strategy generally capitalizes on securities in an upward market trend.
Weekly Price Growth: ALGN vs. PAYC
For the week, ALGN, which operates in the Medical Specialties industry, enjoyed a price increase of 2.56%. In contrast, PAYC, part of the Packaged Software industry, experienced a price drop of 2.34%.
When comparing these numbers to their respective industries, ALGN performed much stronger than its peers with an average weekly price drop of 0.89% in the Medical Specialties sector. PAYC, on the other hand, outperformed its industry, where the average weekly price drop was 1.07%.
Monthly and Quarterly Price Growth: An Industry Perspective
Taking a wider lens, the average monthly and quarterly price growth in the Medical Specialties industry (home to ALGN) was -0.37% and +7.41%, respectively. For the Packaged Software sector (home to PAYC), these figures were +3.70% and a robust +23.99%. The Packaged Software industry, hence, appears to have experienced higher growth over the more extended periods, underlining the importance of considering industry performance when comparing individual stocks.
Upcoming Earnings Reports
As for future expectations, both companies are due to report earnings soon. ALGN is set to announce its earnings on July 26, 2023, while PAYC is expected to report on August 1, 2023. These reports could potentially influence stock prices and should be closely monitored by investors.
In conclusion, while both ALGN and PAYC offer attractive opportunities for swing trading, they do so in distinct market contexts. Traders and investors should bear in mind these differences when devising their strategies and keep a keen eye on the upcoming earnings reports. The ongoing performance of these two companies reaffirms the importance of not only examining individual stocks but also the industries within which they operate.
Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where ALGN declined for three days, in of 342 cases, the price declined further within the following month. The odds of a continued downward trend are .
The Momentum Indicator moved below the 0 level on August 27, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on ALGN as a result. In of 76 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where ALGN's RSI Indicator exited the oversold zone, of 38 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .
The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.
The Moving Average Convergence Divergence (MACD) for ALGN just turned positive on August 19, 2025. Looking at past instances where ALGN's MACD turned positive, the stock continued to rise in of 45 cases over the following month. The odds of a continued upward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ALGN advanced for three days, in of 289 cases, the price rose further within the following month. The odds of a continued upward trend are .
ALGN may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. ALGN’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.437) is normal, around the industry mean (11.051). P/E Ratio (22.223) is within average values for comparable stocks, (57.822). ALGN's Projected Growth (PEG Ratio) (0.780) is slightly lower than the industry average of (1.745). ALGN has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.016). P/S Ratio (2.452) is also within normal values, averaging (17.152).
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ALGN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a manufacturer of the invisalign system for treating malocclusion
Industry PharmaceuticalsOther